Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Review

  • Targeting STAT3 with Proteolysis Targeting Chimeras and Next-Generation Antisense Oligonucleotides
    Jamie V. Shiah, Jennifer R. Grandis, Daniel E. Johnson
    Molecular Cancer Therapeutics Nov 2020, DOI: 10.1158/1535-7163.MCT-20-0599
  • Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer
    Rachel K. Toth, Noel A. Warfel
    Molecular Cancer Therapeutics Jan 2021, 20 (1) 3-10; DOI: 10.1158/1535-7163.MCT-20-0535
  • Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast Cancer
    Sundee Dees, Rajkumar Ganesan, Sanjaya Singh, Iqbal S. Grewal
    Molecular Cancer Therapeutics Dec 2020, 19 (12) 2409-2421; DOI: 10.1158/1535-7163.MCT-20-0385
  • Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer
    Aamod S. Dekhne, Zhanjun Hou, Aleem Gangjee, Larry H. Matherly
    Molecular Cancer Therapeutics Nov 2020, 19 (11) 2245-2255; DOI: 10.1158/1535-7163.MCT-20-0423
  • Ion Channels and Their Role in the Pathophysiology of Gliomas
    Takeshi Takayasu, Kaoru Kurisu, Yoshua Esquenazi, Leomar Y. Ballester
    Molecular Cancer Therapeutics Oct 2020, 19 (10) 1959-1969; DOI: 10.1158/1535-7163.MCT-19-0929
  • Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows
    Patrick J. Roberts, Vishnu Kumarasamy, Agnieszka K. Witkiewicz, Erik S. Knudsen
    Molecular Cancer Therapeutics Aug 2020, 19 (8) 1575-1588; DOI: 10.1158/1535-7163.MCT-18-1161
  • A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting
    Lihua Shu, Dongsheng Wang, Nabil F. Saba, Zhuo G. Chen
    Molecular Cancer Therapeutics Apr 2020, 19 (4) 999-1007; DOI: 10.1158/1535-7163.MCT-19-0660
  • The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
    Scott F. Schoninger, Stacy W. Blain
    Molecular Cancer Therapeutics Jan 2020, 19 (1) 3-12; DOI: 10.1158/1535-7163.MCT-19-0253
  • Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
    Paulo Bergerot, Peter Lamb, Evelyn Wang, Sumanta K. Pal
    Molecular Cancer Therapeutics Dec 2019, 18 (12) 2185-2193; DOI: 10.1158/1535-7163.MCT-18-1399
  • Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
    Benjamin L. Woolbright, Ganeshkumar Rajendran, Robert A. Harris, John A. Taylor
    Molecular Cancer Therapeutics Oct 2019, 18 (10) 1673-1681; DOI: 10.1158/1535-7163.MCT-19-0079

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement